Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 1
Submit an article Journal homepage
1,790
Views
11
CrossRef citations to date
0
Altmetric
Author's View

Cancer cell associated glycans as targets for immunotherapy

Mireille VankemmelbekeDivision of Cancer and Stem Cells; School of Medicine; City Hospital Campus; University of Nottingham; Hucknall Road; Nottingham, UK
,
Jia Xin ChuaDivision of Cancer and Stem Cells; School of Medicine; City Hospital Campus; University of Nottingham; Hucknall Road; Nottingham, UK
&
Lindy G. DurrantDivision of Cancer and Stem Cells; School of Medicine; City Hospital Campus; University of Nottingham; Hucknall Road; Nottingham, UKCorrespondence[email protected]
Article: e1061177 | Received 21 May 2015, Accepted 05 Jun 2015, Published online: 22 Oct 2015

References

  • Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science 2014; 343:1235681; PMID:24385630; http://dx.doi.org/10.1126/science.1235681
  • Drake RR. Glycosylation and cancer: moving glycomics to the forefront. Adv Cancer Res 2015; 126:1-10; PMID:25727144; http://dx.doi.org/10.1016/bs.acr.2014.12.002
  • Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005; 5:526-42; PMID:16069816; http://dx.doi.org/10.1038/nrc1649
  • Hakomori SI, Cummings RD. Glycosylation effects on cancer development. Glycoconj J 2012; 29:565-6; PMID:22996057; http://dx.doi.org/10.1007/s10719-012-9448-4
  • Rabu C, McIntosh R, Jurasova Z, Durrant L. Glycans as targets for therapeutic antitumor antibodies. Future Oncol 2012; 8:943-60; PMID:22894669; http://dx.doi.org/10.2217/fon.12.88
  • Chua JX, Vankemmelbeke M, McIntosh RS, Clarke PA, Moss R, Parsons T, Spendlove I, Zaitoun AM, Madhusudan S, Durrant LG. Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor Activity. Clin Cancer Res 2015; 21(13):2963-74; http://dx.doi.org/10.1158/1078-0432.CCR-14-3030
  • Stanley P, Cummings RD. Structures Common to Different Glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, eds. Essentials of Glycobiology: Cold Spring Harbor, NY, 2009.
  • Alduaij W, Ivanov A, Honeychurch J, Cheadle EJ, Potluri S, Lim SH, Shimada K, Chan CH, Tutt A, Beers SA et al. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood 2011; 117:4519-29; PMID:21378274; http://dx.doi.org/10.1182/blood-2010-07-296913
  • Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12:860-75; PMID:23151605; http://dx.doi.org/10.1038/nrc3380
  • Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget 2014; 5:5190-1; PMID:25114034

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.